IMCAS 2017


Our News

IMCAS World Congress 2017

LINLINE Medical Systems is delighted to attend this year’s World Congress 26th to 29th January 2017, at the Palais des Congrès, Paris, which promises to be the event of the year!

Come and visit us at our booth A7, Level 2.

Speakers who will tell about their experience with new technologies from LINLINE:

Odoo image and text block


Professor and Head of the Department of Plastic and maxillofacial Surgery at the Henri Mondor University Hospital, Paris

Date: Thursday 26 January 2017 at 11:00 to 12:00

Room: Room8

Lecture title: Facial skin rejuvenation - Multi-fractional microablative laser combined with SMA technology



Due to the increasing demand for aesthetic procedures, especially facial aesthetic surgery, a new laser technology has been developed for facial skin rejuvenation and wrinkle treatment.

The aim of this study was to objectively and subjectively assess the clinical efficacy and safety of Erbium:YAG laser combined with Space Modulated Ablation (Er:YAG+SMA) on facial skin rejuvenation.

Materials and Methods

Patients with Fitzpatrick skin types I-IV were prospectively included. Inclusion criteria were having wrinkles and irregular skin texture. All patients underwent two Er:YAG+SMA sessions one month apart to stimulate tissue regeneration. Er:YAG laser emits wavelength at 2,940 nm and, when combined with SMA, a resonance effect is produced in the dermis to promote tissue regeneration.

Facial skin elasticity and firmness were objectively assessed by cutometry at baseline and month 6 (M6). Aesthetic improvement was qualitatively assessed using digital photographs. Patient satisfaction with their facial appearance was self-assessed using the validated FACE-Q scale and aging appraisal scale at baseline, M1 and M6. Side effects were investigated after each session.


Thirty-four patients were included, 50% (18 patients) had Fitzpatrick skin type III and 41% (14 patients) were smokers.

Skin elasticity indices were significantly improved: from 0.335±0.015 at baseline to 0.387±0.021 at M6 (p=0.05*) for R5 (net elasticity). Skin firmness was assessed through R7 (biological elasticity) and R6 (viscoelastic ratio) at baseline and M6.

The FACE-Q scores were significantly increased from 39.4±6.7 at baseline to 45.4±9.1 at M1 (p<0.006***) and 50.4±9.8 at M6 (p<0.0001***), reflecting wrinkle reduction and enhanced rejuvenation. Aging appraisal scale showed that patients felt younger by -2.92 years at M1 (p<0.0001***) and -4.13 years (p<0.0001***) at M6. 

The Er:YAG+SMA technology offers an effective and safe treatment alternative for facial skin rejuvenation..


MD and PhD Maxima Cum Laude, General Surgeon, Plastic Aesthetic and Reconstructive Surgeon.

Date: Saturday 28 January 2017 at 08:00 to 10:00

Room: Blue courtyard

Lecture title: Ablative laser resurfacing on dark skins  


Odoo text and image block


This clinical study reports on the efficacy and safety of a method of facial rejuvenation using a 2940 – nm Erbium:YAG laser. This study was performed in women moderate to severe signs of facial aging relative to chronological age, who underwent two treatment sessions with an Er:YAG laser coupled to an optical system which converts the original beam in ten thousand micro beams per square cm. 

The whole face was treated in all patients. Clinical efficacy, tolerance, adverse effects, complications, and histological changes due to the treatment, were evaluated. Photographs and biopsies were taken before treatment and 3 months after the second treatment session. All patients completed the study and presented no significant complications. Histological changes in the epidermis and dermis as a result of treatment were found. Fine lines, wrinkles and overall facial aging improved significantly (p<0.0001). The mean reduction of fine lines and wrinkles was 59% (r=40% - 75%). The mean improvement of overall facial aging was 74% (r=55% - 90%). After showing the patients the comparative photographs before and after treatment, 75% of women stated that they were satisfied or very satisfied, and would recommend the treatment. Preliminary results show an excellent safety/efficacy profile for this technology which, based on observed results, is consider to have advantages over other methods of facial rejuvenation with lasers, particularly on dark skin phototypes.

Odoo image and text block

Dr Natalia VOLKOVA


Laser technologies


Date: Sunday 29 January 2017 at 11:30 to 12:30

Room: Room6

Lecture title: The innovative laser technology -Er:YAG laser equipped with SMA-module- for the non-surgical lifting of the facial soft tissues. The results of clinical trial


Facial ageing is a complex biological process that affects the skin and underlying tissues including SMAS. Age-related changes of the dermis lead to wrinkle formation. Age-related changes of SMAS lead to soft tissue ptosis. Reconstructive Spatially Modulated Ablation is an innovative laser technology.It’s a microablative method of acoustic-interference microinjury of the tissues using an Er:YAG laser(2940 nm) equipped with a special module–SMA(5 mm).

The main idea of the technology is creation of acoustic waves through explosive vaporisation in the upper layer of epidermis.The depth of penetration of acoustic waves is up to 6 mm.

Materials and methods

71 outpatients were obtained (68female, 3male; 34-72 y/o).Patients underwent one RecoSMA treatment(3Hz;2,21J/cm2).The ultrasound skin examination(22MHz) was done before; on 30th, 90th days after the procedure.Results:Recovery time-4-6 days;there were no complications.The ultrasound skin examination detected the average value of dermis density: baseline-12,64; on the 30th days after–13,45;on the 90th days–16,08.The increasing of dermis density on 30th days after laser treatment was 6,43%; on 90th days–27,22%(p<0,05).The average value of SMAS thickness: baseline–180,38 mkm;on the 30th days after–209,1 mkm; on the 90th days–239,87.The increasing of SMAS thickness on 30th days after treatment achieved 15,92%;on 90th days–32,98%(p<0,05).The average value of SMAS density: baseline-18,93; on the 30th days after–20,84; on the 90th days–27,39.The increasing of dermis density on 30th days after RecoSMA treatment-10,09%; on 90th days–44,69%(p<0,05).The skin changes were presented with decrease of wrinkle depth and significant lifting of facial soft tissues.


The increasing of thickness and density of the dermis and SMAS indicates the increase in the number of cell structures in these layers and confirms processes of collagen synthesis which leads to decreasing of the wrinkle depth and lifting of soft tissues of the face.